Inventor · disambiguated record
Hirotatsu Kojima
Also filed as: KOJIMA HIROTATSU
15 granted patents·16 pending applications·231 citations·filing 1997–2017
93Inventor score
Files withUNIV TOKYO11NAGANO TETSUO9DAIICHI PURE CHEMICALS CO LTD5SEKISUI MEDICAL CO LTD2TETSUO NAGANO2
Top patents by PatentIndex Score
31 records- 0195US6569892B2Diaminofluorescein derivativesDAIICHI PURE CHEMICALS CO LTD·Filed 2002·Granted May 27, 2003·37 cites·10 claims
- 0291US6469051B2Diaminorhodamine derivativeNAGANO TETSUO·Filed 2000·Granted Oct 22, 2002·29 cites·23 claims
- 0389US6441197B1Diaminofluorescein derivativeDAIICHI PURE CHEMICALS CO LTD·Filed 2000·Granted Aug 27, 2002·27 cites·11 claims
- 0489US6201134B1Diaminorhodamine derivativesNAGANO TESTUO·Filed 1998·Granted Mar 13, 2001·39 cites·5 claims
- 0588US6756231B1Diaminorhodamine derivativeDAIICHI PURE CHEMICALS CO LTD·Filed 2000·Granted Jun 29, 2004·22 cites·8 claims
- 0688US5874590ADiaminofluorescein derivativeNAGANO TETSUO·Filed 1997·Granted Feb 23, 1999·43 cites·11 claims
- 0787US6833386B2Diaminofluorescein derivativesDAIICHI PURE CHEMICALS CO LTD·Filed 2003·Granted Dec 21, 2004·21 cites·3 claims
- 0886US7618997B2Diaminofluorescein derivativesSEKISUI MEDICAL CO LTD·Filed 2006·Granted Nov 17, 2009·3 cites·16 claims
- 0974US10189843B2Fused pyrazole derivative having autotaxin inhibitory activityUNIV TOKYO·Filed 2015·Granted Jan 29, 2019·3 cites·11 claims
- 1071US2010029010A1Diaminorhodamine DerivativeNAGANO TETSUO·Filed 2009·Application pending·0 cites
- 1169US10183949B2Pyrimidinone derivative having autotaxin-inhibitory activityUNIV TOKYO·Filed 2017·Granted Jan 22, 2019·1 cites·16 claims
- 1268US9156827B2Anticancer agentNAGANO TETSUO·Filed 2011·Granted Oct 13, 2015·2 cites·6 claims
- 1365US8465985B2Fluorescent probeNAGANO TETSUO·Filed 2008·Granted Jun 18, 2013·4 cites·7 claims
- 1464US2008014147A1Tumor specific fluorescent dyeUNIV TOKYO·Filed 2007·Application pending·0 cites
- 1559US2010330685A1Diaminorhodamine derivativeSEKISUI MEDICAL CO LTD·Filed 2010·Application pending·0 cites
- 1658US8507677B2Fluorescent probeNAGANO TETSUO·Filed 2008·Granted Aug 13, 2013·0 cites·25 claims
- 1758US2008108141A1Diaminorhodamine derivativeNAGANO TETSUO·Filed 2007·Application pending·0 cites
- 1854US2011111515A1Reagent for measurement of reactive oxygenUNIV TOKYO·Filed 2009·Application pending·0 cites
- 1954US2016289728A1Method for detecting fluorescence or absorbance, method for suppressing background, method for measuring adp, method for measuring activity of adp-synthesizing enzyme, and method for measuring activity of glucosyltransferaseUNIV TOKYO·Filed 2014·Application pending·0 cites
- 2054US2004147035A1Diaminorhodamine derivativeDAIICHI PURE CHEMICALS CO LTD·Filed 2003·Application pending·0 cites
- 2153US2006252099A1Method for measurement by using long-lived excitation fluorescenceTETSUO NAGANO·Filed 2006·Application pending·0 cites
- 2253US2011165085A1Tumor selective fluorescent staining agentUNIV TOKYO·Filed 2011·Application pending·0 cites
- 2349US7939330B2Fluorescent probeNAGANO TETSUO·Filed 2010·Granted May 10, 2011·0 cites·4 claims
- 2445US2003157727A1Measuring method using long life fluorescence of excitation typeFiled 2001·Application pending·0 cites
- 2544US2005130314A1Diaminofluorescein derivativesTETSUO NAGANO·Filed 2004·Application pending·0 cites
- 2644US2016368895A1Pulmonary hypertension treating agentUNIV TOKYO·Filed 2014·Application pending·0 cites
- 2744US2007298507A1Fluorescent ProbeNAGANO TETSUO·Filed 2005·Application pending·0 cites
- 2843US2008281104A1Membrane-Anchoring Fluorescent ProbeUNIV TOKYO·Filed 2006·Application pending·0 cites
- 2941US2016002247A18-substituted imidazopyrimidinone derivative having autotaxin inhibitory activityUNIV TOKYO·Filed 2014·Application pending·0 cites
- 3033US10689394B2Thieno[2,3-b]pyridine derivative, quinoline derivative, and use thereofUNIV TOKYO·Filed 2017·Granted Jun 23, 2020·0 cites·18 claims
- 3130US2017145005A1Kinase inhibitorUNIV TOKYO·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →